Related Experiment Video
Updated: May 5, 2026
11:27
A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
1.8K
Crystal polymorphs of barbital: news about a classic polymorphic system
Neslihan Zencirci1, Ulrich J Griesser, Thomas Gelbrich
1Institute of Pharmacy, University of Innsbruck , Innrain 52, 6020 Innsbruck, Austria.
Molecular Pharmaceutics
|November 29, 2013
Summary
This study clarifies the complex polymorphic system of barbital, a hypnotic agent. Researchers mapped thermodynamic relationships and stability, revealing distinct solid-state forms and their interconversions.
Area of Science:
- Pharmaceutical Chemistry
- Solid-State Chemistry
- Crystallography
Background:
- Barbital, a long-studied hypnotic agent, possesses a complex polymorphic system.
- Understanding these solid forms is crucial for drug formulation and stability.
Purpose of the Study:
- To elucidate the polymorphic system of barbital.
- To establish thermodynamic relationships between different solid forms.
- To construct an energy/temperature diagram for barbital polymorphs.
Main Methods:
- Characterization of four barbital solid forms (I(0), III, IV, V) using analytical techniques.
- Determination of thermodynamic relationships and transition points.
- Solid-state Nuclear Magnetic Resonance (NMR) spectroscopy and Infrared (IR) spectroscopy.
Main Results:
- Construction of the first semischematic energy/temperature diagram for barbital.
- Identification of enantiotropic and monotropic relationships between polymorphs.
- Established thermodynamic stability order at room temperature: I(0) > III > V > IV.
- Metastable form III, found in commercial samples, exhibits high kinetic stability.
- Solid-state NMR provided crystallographic insights, including hydrogen bonding patterns.
Conclusions:
- The study provides a comprehensive understanding of barbital's polymorphic behavior.
- Thermodynamic and crystallographic data are essential for predicting and controlling solid-state properties.
- The findings contribute to the rational design and development of pharmaceutical formulations.
Related Concept Videos
01:21Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
887
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
887
01:20Sedatives and Hypnotics Drugs: Barbiturates
1.5K
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.5K
01:24The Seven Crystal Systems: Overview
298
Crystals with various point group symmetries belong to different crystal classes, which are synonymous terms. Despite being in the same class, crystals may have distinct shapes, like cubes and octahedra. There are 32 three-dimensional point groups, all of which are systematically divided into seven crystal systems.The basic cubic crystal system, exemplified by NaCl, features orthogonal vectors (α = β = �� = 90°) of equal lengths (a = b = c). When specific...
298
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.9K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.9K
01:21Polymer Classification: Crystallinity
3.1K
Unlike ionic or small covalent molecules, polymers do not form crystalline solids due to the diffusion limitations of their long-chain structures. However, polymers contain microscopic crystalline domains separated by amorphous domains.
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
3.1K